LFMD

4.10% -0.225

Dopo l'orario di chiusura: 5.40 0.14 +2.66%

Lifemd Inc (LFMD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché LFMD Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Lifemd Inc Stock (LFMD) Company Profile

Healthcare (1196)

(866) 351-5907

236 FIFTH AVENUE, NEW YORK

Prossima data di guadagno

Ultimi documenti SEC

LFMD's Discussions on Twitter

Confronta LFMD con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LFMD	5.26	227.82M	193.06M	-22.51M	10.63M	-1.04
VEEV	213.68	34.73B	2.57B	615.26M	996.76M	3.32
SOLV	67.12	11.43B	8.25B	404.00M	1.52B	0.00
DOCS	52.21	9.58B	493.63M	160.55M	162.20M	0.55
HQY	102.40	8.82B	1.10B	105.67M	-197.98M	0.1475
TEM	54.06	8.51B	640.44M	-743.28M	-206.93M	0.00

Lifemd Inc Stock (LFMD) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-03-10	Iniziato	Colliers Securities	Buy
2021-10-04	Ripresa	B. Riley Securities	Buy

Lifemd Inc Borsa (LFMD) Ultime notizie

Lifemd Inc Azioni (LFMD) Dati Finanziari

Lifemd Inc (LFMD)

Lifemd Inc Stock (LFMD) Company Profile

Confronta LFMD con altri titoli

Lifemd Inc Stock (LFMD) Upgrades & Downgrades

Lifemd Inc Borsa (LFMD) Ultime notizie

Los Angeles Capital Management LLC Acquires 108,822 Shares of LifeMD, Inc. (NASDAQ:LFMD) - MarketBeat

LifeMD (LFMD) to Present at Three Major Healthcare Investor Conferences in November | LFMDP Stock News - StockTitan

LifeMD to Participate in Three Investor Conferences During November - The Manila Times

LifeMD (LFMD) to Present at Three Major Healthcare Investor Conferences in November | LFMD Stock News - StockTitan

LifeMD Inc (NASDAQ: LFMD) Could Pass $12 In One Year Stock Forecast - Stocks Register

HC Wainwright Reiterates Buy Rating for LifeMD (NASDAQ:LFMD) - MarketBeat

LifeMD, Inc. (NASDAQ:LFMD) Q3 2024 Earnings Call Transcript - Insider Monkey

LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 31% Yet They're Still Not Telling The Full Story - Simply Wall St

LifeMD Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance

(LFMD) Technical Pivots with Risk Controls - Stock Traders Daily

LifeMD Inc (LFMD) Q3 2024 Earnings Call Highlights: Strong Teleh - GuruFocus.com

LifeMD Inc (LFMD) Q3 2024 Earnings Call Highlights: Strong Telehealth Growth and Strategic ... - Yahoo Finance

LifeMD, Inc. (LFMD) Reports Q3 Loss, Lags Revenue Estimates - MSN

LifeMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

LifeMD earnings beat by $0.21, revenue fell short of estimates - Investing.com UK

LifeMD Reports Third Quarter 2024 Results - GlobeNewswire

Institutions profited after LifeMD, Inc.'s (NASDAQ:LFMD) market cap rose US$39m last week but individual investors profited the most - Simply Wall St

Earnings to Watch: LifeMD Inc (LFMD) Reports Q3 2024 Result - GuruFocus.com

LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency - The Manila Times

Brokerages Set LifeMD, Inc. (NASDAQ:LFMD) Target Price at $12.00 - Defense World

Medifast Announces Third Quarter 2024 Financial Results - StockTitan

LifeMD, Inc. (NASDAQ:LFMD) Given Average Rating of "Buy" by Brokerages - MarketBeat

LifeMD announces board member resignation By Investing.com - Investing.com Australia

LifeMD announces board member resignation - Investing.com India

LifeMD stock touches 52-week low at $4.03 amid market challenges - Investing.com Canada

LifeMD (LFMD) Set to Announce Earnings on Thursday - MarketBeat

LifeMD Shares Decline Even After the Launch of Testosterone Therapy - MSN

LifeMD® To Report Third Quarter 2024 Financial Results On November 7 - Barchart

LifeMD launches TestoRx, direct to consumer testosterone replacement therapy - Yahoo Finance

LifeMD® to Report Third Quarter 2024 Financial Results on November 7 - GlobeNewswire

LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer - GlobeNewswire

LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering - Yahoo Finance

The Manufacturers Life Insurance Company Purchases Shares of 13,551 LifeMD, Inc. (NASDAQ:LFMD) - Defense World

Trading Day Review: LifeMD Inc (LFMD) Gains Momentum, Closing at 4.64 - The Dwinnex

LifeMD shares hold as BTIG maintains $12 target By Investing.com - Investing.com Australia

LifeMD shares hold as BTIG maintains $12 target - Investing.com

Is it possible to buy LifeMD Inc(LFMD) shares at a good price now? - US Post News

LifeMD, Inc.'s (NASDAQ:LFMD) top owners are retail investors with 45% stake, while 38% is held by institutions - Yahoo Finance

LifeMD Inc [LFMD] stock for 14,790 USD was bought by Galluppi Stefan - Knox Daily

LifeMD Inc (LFMD) Stock: A Year of Declines and Increases - The InvestChronicle

Financial Health Check: Examining LifeMD Inc (LFMD)’s Key Ratios - The Dwinnex

LifeMD shares maintain Buy rating from B.Riley amid market demand By Investing.com - Investing.com South Africa

LifeMD Inc (LFMD) Q2 2024 Earnings Call Highlights: Strong Telehealth Growth and Strategic ... - Yahoo Finance

LifeMD shares maintain Buy rating from B.Riley amid market demand - Investing.com

Brokerages Set LifeMD, Inc. (NASDAQ:LFMD) PT at $12.00 - MarketBeat

LifeMD Inc (LFMD)’s results reveal risk - US Post News

Trend Tracker for (LFMDP) - Stock Traders Daily

LifeMD stock well-positioned as branded prescriptions gain traction – BTIG By Investing.com - Investing.com Canada

LifeMD Inc [LFMD] stock for 14,790 USD was acquired by Galluppi Stefan - Knox Daily

Lifemd Inc Azioni (LFMD) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a LFMD